{"id":778884,"date":"2025-12-10T10:28:01","date_gmt":"2025-12-10T10:28:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=778884"},"modified":"2025-12-10T10:28:01","modified_gmt":"2025-12-10T10:28:01","slug":"remote-patient-monitoring-market-global-growth-key-drivers-and-future-outlook-through-2030","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/remote-patient-monitoring-market-global-growth-key-drivers-and-future-outlook-through-2030_778884.html","title":{"rendered":"Remote Patient Monitoring Market: Global Growth, Key Drivers, and Future Outlook Through 2030"},"content":{"rendered":"
\n
\"Remote<\/a><\/div>\n
\n
Prominent players in the Remote patient monitoring market include Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Corporation (Japan), GE Healthcare (US), Oracle (US), Boston Scientific Corporation (US), Abbott (US), NIHON KOHDEN CORPORATION (Japan), Siemens Healthineers AG (Germany)<\/div>\n<\/div>\n<\/div>\n
Browse 354 market data Tables and 64 Figures spread through 395 Pages and in-depth TOC on “Remote Patient Monitoring (RPM) Market by Offering (Software, integrated device), Device (Wearable, implants, handheld), Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio, Neuro), End user, & Region – Global Forecast to 2030<\/div>\n

The Remote Patient Monitoring (RPM) Market<\/strong> is experiencing strong global growth as healthcare systems shift toward home-based care, chronic disease management, and digital health transformation. Valued at US$24.39 billion in 2023<\/strong>, the market is expected to reach US$27.72 billion in 2024<\/strong> and grow at an impressive CAGR of 12.7%<\/strong>, ultimately hitting US$56.94 billion by 2030<\/strong>. This rapid expansion reflects rising demand for continuous health monitoring, broader telehealth adoption, and increasing investments in connected medical technologies.<\/p>\n

As healthcare providers aim to reduce hospital admissions, improve patient outcomes, and lower overall care costs, remote patient monitoring has become essential across cardiology, diabetes care, respiratory conditions, and mental health management. The integration of AI, wearable devices, and cloud-based platforms is further accelerating the adoption of RPM systems worldwide.<\/p>\n

Download PDF Brochure: https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=77155492<\/a><\/strong><\/p>\n

Key Factors Driving Market Growth<\/strong> 1. Rising Chronic Disease Burden<\/strong><\/p>\n

Chronic illnesses—including heart disease, diabetes, COPD, hypertension, and cancer—continue to grow worldwide. RPM solutions enable early detection of complications, continuous monitoring outside clinical settings, and timely interventions, making them a crucial part of long-term disease management.<\/p>\n

2. Shift Toward Home Healthcare<\/strong><\/p>\n

Patients and healthcare systems increasingly prefer home-based care<\/strong>, which offers lower costs, greater comfort, and reduced hospital visits. Remote patient monitoring provides clinicians with real-time data, helping them manage patients remotely while maintaining high-quality care standards.<\/p>\n

3. Advances in Wearable and Connected Health Technology<\/strong><\/p>\n

Wearable medical devices—such as ECG patches, blood glucose monitors, smartwatches, and wireless vital sign trackers—are becoming more accurate, affordable, and user-friendly. Innovations such as AI-enabled sensors, continuous monitoring devices, and smartphone-integrated diagnostics are transforming how patients track vital signs.<\/p>\n

4. Digital Transformation of Healthcare<\/strong><\/p>\n

AI, machine learning, and cloud platforms are reshaping remote patient monitoring. These technologies support predictive analytics, early warnings of health deterioration, automated triaging, and personalized care pathways. With digitalization accelerating across global healthcare systems, RPM adoption continues to intensify.<\/p>\n

5. Government Support and Reimbursement Programs<\/strong><\/p>\n

Programs like the FCC’s COVID-19 Telehealth Program<\/strong> and Rural Health Care Program<\/strong> are improving broadband access in underserved regions, enabling hospitals and clinics to deliver remote care. While the pandemic drove initial momentum, ongoing investment in telehealth infrastructure and reimbursement models continues to support long-term growth.<\/p>\n

Challenges Hindering Broader Adoption<\/strong><\/p>\n

Despite strong market potential, several hurdles remain: • Limited digital literacy among elderly populations • Uneven broadband access in rural regions • Reimbursement variability across countries • Data security and privacy concerns • Integration issues with existing hospital systems<\/p>\n

These challenges must be addressed to achieve widespread RPM adoption in both developed and emerging markets.<\/p>\n

Market Segmentation by Indication<\/strong><\/p>\n

The remote patient monitoring market spans a range of clinical areas, including: • Oncology • Cardiology • Neurology • Diabetes • Respiratory diseases • Sleep disorders • Mental health • Wellness improvement • Other chronic conditions<\/p>\n

Cardiology Dominated the Market in 2023<\/strong><\/p>\n

Cardiology held the largest share of the RPM market in 2023 due to the rising global incidence of heart failure, hypertension, arrhythmias, and post-operative cardiac complications. RPM programs allow clinicians to track blood pressure, heart rhythm, ECG data, oxygen levels, and other vital signs remotely.<\/p>\n

Key Innovations Supporting Segment Growth<\/strong><\/p>\n

• Medtronic’s PulseSelect Pulse Field Ablation (PFA) System<\/strong>, FDA-cleared for arrhythmia treatment • HeartBeam’s credit card–sized heart monitor<\/strong>, designed for portable cardiac diagnostics • FDA clearances for AI models in cardiology<\/strong>—now exceeding 1,000 approvals • Withings’ AI-powered smart mirrors<\/strong> showcased at CES 2025 • Reduced readmissions and hospital stays, as reported by Atrium Health’s RPM program<\/strong> in North Carolina<\/p>\n

These advancements highlight the rising role of remote technologies and AI in cardiovascular care.<\/p>\n

Market Segmentation by Component<\/strong><\/p>\n

The remote patient monitoring market is divided into: • Software • Services • Devices<\/p>\n

Software Segment to Register the Fastest CAGR<\/strong><\/p>\n

Software is expected to experience the highest growth rate between 2024 and 2030 due to: • Increasing demand for AI- and ML-powered analytics • Higher adoption of cloud-based healthcare platforms • Rapid expansion of telemedicine • Need for data-driven decision-making • Growing integration of EHRs with monitoring platforms<\/p>\n

RPM software enables patient data collection, risk stratification, automated alerts, and remote clinician dashboards. As healthcare delivery models shift toward hybrid and virtual care, advanced RPM software will continue to gain momentum.<\/p>\n

Regional Outlook<\/strong><\/p>\n

The remote patient monitoring market is geographically segmented into: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.<\/strong><\/p>\n

North America Leads the Global Market<\/strong><\/p>\n

North America accounted for the largest share in 2023 due to: • High adoption of telehealth and connected care • Strong presence of leading RPM vendors • Significant investment in digital health technologies • Favorable reimbursement for chronic care management and remote monitoring • Rapid integration of AI in clinical workflows<\/p>\n

The US remains the largest market globally, with hospitals expanding RPM programs for cardiac care, diabetes management, and post-surgical monitoring.<\/p>\n

Asia Pacific is the Fastest-Growing Region<\/strong><\/p>\n

Asia Pacific is witnessing rapid growth driven by: • Expanding pharmaceutical and medtech sectors • Growing prevalence of chronic diseases • Rising number of telehealth and RPM start-ups • Affordable device manufacturing • Less-stringent regulatory requirements in some countries<\/p>\n

China, India, Japan, South Korea, Australia, and Singapore are emerging as strong RPM markets due to supportive digital health initiatives and increased healthcare investments.<\/p>\n

Competitive Landscape<\/strong><\/p>\n

The remote patient monitoring market is highly competitive, with major players investing in AI integration, device miniaturization, and cloud-based platforms. Key companies include:<\/p>\n

• Koninklijke Philips N.V. (Netherlands)<\/strong> • Medtronic (Ireland)<\/strong> • OMRON Corporation (Japan)<\/strong> • GE Healthcare (US)<\/strong> • Oracle (US)<\/strong> • Boston Scientific (US)<\/strong> • Abbott (US)<\/strong> • Nihon Kohden Corporation (Japan)<\/strong> • Siemens Healthineers (Germany)<\/strong> • Baxter (US)<\/strong> • Biobeat (Israel)<\/strong> • Biotronik (Germany)<\/strong> • VitalConnect (US)<\/strong> • VivaLNK (US)<\/strong> • Clear Arch (US)<\/strong> • Optum (Vivify Health) (US)<\/strong> • Lightbeam Health Solutions (US)<\/strong> • Cloud Diagnostics Canada (Canada)<\/strong> • Teladoc Health (US)<\/strong> • Transtek Medical (China)<\/strong> • CareSimple (Canada)<\/strong> • TimeDoc Health (US)<\/strong> • MD Revolution (US)<\/strong> • Optimize Health (US)<\/strong> • Health Recovery Solutions (US)<\/strong> • Current Health (US)<\/strong> • Tenovi (US)<\/strong><\/p>\n

These companies are expanding their portfolios through innovation in wearable sensors, diagnostics, AI algorithms, and virtual care platforms.<\/p>\n

Conclusion<\/strong><\/p>\n

The Remote Patient Monitoring Market<\/strong> is poised for significant expansion through 2030, driven by advancements in wearable technology, AI-powered analytics, rising chronic disease burden, and global efforts to modernize healthcare delivery. While challenges such as reimbursement complexities, digital literacy, and infrastructure gaps persist, continued innovation and strong government support are expected to accelerate RPM adoption worldwide.<\/p>\n

Request Sample Pages: <\/strong>https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=77155492<\/a><\/strong><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> MarketsandMarkets\u2122 Research Private Ltd.<\/a>
Contact Person:<\/strong> Mr. Rohan Salgarkar
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 18886006441
Address:<\/strong>1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City:<\/strong> Florida
State:<\/strong> Florida
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.marketsandmarkets.com\/Market-Reports\/remote-patient-monitoring-market-77155492.html<\/a><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Prominent players in the Remote patient monitoring market include Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Corporation (Japan), GE Healthcare (US), Oracle (US), Boston Scientific Corporation (US), Abbott (US), NIHON KOHDEN CORPORATION (Japan), Siemens Healthineers AG (Germany) Browse 354 market … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,403,404,416],"tags":[],"class_list":["post-778884","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-UK","category-US","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/778884","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=778884"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/778884\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=778884"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=778884"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=778884"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}